Format

Send to

Choose Destination
Expert Rev Mol Med. 2008 Oct 13;10:e29. doi: 10.1017/S1462399408000835.

Immune defence mechanisms and immunoenhancement strategies in oropharyngeal candidiasis.

Author information

1
Department of Periodontics, University of Texas Health Science Center at San Antonio School of Dentistry, San Antonio, Texas 78229, USA. villar@uthscsa.edu

Abstract

The prevalence of oropharyngeal candidiasis continues to be high, mainly because of an increasing population of immunocompromised patients. Traditional treatment of oropharyngeal candidiasis has relied on the use of antimicrobial drugs. However, unsatisfactory results with drug monotherapy and the emergence of resistant strains have prompted investigations into the potential use of adjunctive immunoenhancing therapies for the treatment of these infections. Here we review the host-recognition systems of Candida albicans, the immune and inflammatory response to infection, and antifungal effector mechanisms. The potential of immune modulation as a therapeutic strategy in oropharyngeal candidiasis is also discussed.

PMID:
18847522
PMCID:
PMC2712880
DOI:
10.1017/S1462399408000835
[Indexed for MEDLINE]
Free PMC Article

Supplemental Content

Full text links

Icon for Cambridge University Press Icon for PubMed Central
Loading ...
Support Center